IGEV
LMTG 11-02
Phase 2 small_molecule active
Quick answer
IGEV for Hodgkin Lymphoma is a Phase 2 program (small_molecule) at Fudan University with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Fudan University
- Indication
- Hodgkin Lymphoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active